Vyhláška, kterou se mění vyhláška č. 532/2005 Sb., o úhradách léčiv a potravin pro zvláštní lékařské účely, ve znění vyhlášky č. 37/2006 Sb
| 59.14 | C01CE01 | amrinon | parent. | 0.50 | GM | 3 795,88 | H |
|---|---|---|---|---|---|---|---|
| 59.15 | C01CE02 | milrinon | parent. | 50.00 | MG | 3 609.97 | H |
| 60 | vazodilatační látky pro srdeční onemocnění, perorální podání pro chronickou léčbu | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 60.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5.00 | MG | 1,85 | |
| 60.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5.00 | MG | 2,63 | |
| 13467 | NITROPELET 2.5 | por cps pro30x2.5mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 13468 | NITROPELET 2.5 | por cps pro30x2.5mg | ZEH | SK | |||
| 60.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5.00 | MG | 1,96 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 60.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60.00 | MG | 3,24 | |
| 47758 | ISOPELET20 | por cps pro 30x20mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 60.5 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60.00 | MG | 1,15 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 60.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60.00 | MG | 2,31 | |
| 47762 | ISOPELET40 | por cps pro 30x40mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 47765 | ISOPELET60 | por cps pro 20x60mg | ZEH | SK | |||
| 60.7 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60.00 | MG | 3,89 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 21453 | CARDIKET RETARD 120 | por cps pro30x120mg | SWP | D | |||
| --- | --- | --- | --- | --- | |||
| 91591 | CARDIKET RETARD 120 | cps ret 20x120mg | SWP | D | |||
| 60.8 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40.00 | MG | 2,28 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 20159 | MONOTAB 20 | por tbl nob 20x20mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 23305 | MONOSAN 20 MG | por tbl nob100x20mg | PMP | CZ | |||
| 47686 | ISMIN AL 20 | por tbl nob 60x20mg | APA | D | |||
| 47687 | ISMIN AL 20 | por tbl nob100x20mg | APA | D | |||
| 61467 | ISMN AL 20 | por tbl nob100x20mg | APA | D | |||
| 76401 | SORBIMON 20 MG | tbl 50x20mg | MCK | D | |||
| 76402 | SORBIMON 20 MG | tbl 100x20mg | MCK | D | |||
| 96187 | MONOSAN 20 MG | por tbl nob 50x20mg | PMP | CZ | |||
| 60.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40.00 | MG | 1,77 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 20301 | MONOTAB 40 | por tbl nob 20x40mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 21793 | MONOTAB SR | por tbl pro20x100mg | ZEH | SK | |||
| 21794 | MONOTAB SR | por tbl pro50x100mg | ZEH | SK | |||
| 21795 | MONOTAB SR | por tblprol100x100mg | ZEH | SK | |||
| 23306 | MONOSAN 40 MG | por tbl nob100x40mg | PMP | CZ | |||
| 47690 | ISMIN AL 40 | por tbl nob100x40mg | APA | D | |||
| 76403 | SORBIMON 40 MG | tbl 20x40mg | MCK | D | |||
| 76404 | SORBIMON 40 MG | tbl 50x40mg | MCK | D | |||
| 76405 | SORBIMON 40 MG | tbl 100x40mg | MCK | D | |||
| 60.10 | C01DX03 | oxifedrin | p.o. | 40.00 | MG | 4,68 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 60.11 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6.00 | MG | 4,15 | |
| 49553 | MOLSIHEXAL 2 MG | tbl 100x2mg | SFS | D | |||
| --- | --- | --- | --- | --- | |||
| 60.12 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6.00 | MG | 2,53 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 49554 | MOLSIHEXAL 4 MG | tbl 100x4mg | SFS | D | |||
| --- | --- | --- | --- | --- | |||
| 60.13 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6.00 | MG | 1,45 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | SFS | D | |||
| --- | --- | --- | --- | --- | |||
| 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | SFS | D | |||
| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | SFS | D | |||
| 61 | vazodilatační látky pro srdeční onemocnění, perorální podání pro akutní léčbu | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 61.1 | C01DA02 | glycerol trinitrát | spr. | 5.00 | DF | 2,38 | |
| 61.2 | C01DA02 | glycerol trinitrát | sublng. | 2.50 | MG | 5,82 | |
| 00231 | NITROGLYCERIN-SLOVAKOFARMA | tbl 20x0.5mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 61.3 | C01DA08 | isosorbid dinitrát | sublng. | 20.00 | MG | 2,96 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 61.4 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20.00 | MG | 8,60 | |
| 62 | prostaglandiny a jiná kardiaka | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 62.1 | C01EA01 | alprostadil | parent. | 0.50 | MG | 2 449.19 | B/P |
| 44169 | ALPROSTAPINT 500 MCG/ML | inf cnc sol 5x1 ml | BGD | D | |||
| --- | --- | --- | --- | --- | |||
| 62.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20.00 | RG | 526.96 | B/P |
| --- | --- | --- | --- | --- | --- | --- | --- |
Alprostadil s obsahem 0,5 mg předepisuje pediatr k udržení průchodnosti ductus arteriosus do provedení srdeční operace a pro pacienty s těžkou srdeční nedostatečností, u kterých je plánována transplantace srdce.
Alprostadil s obsahem 20 rg alprostadilu je předepisován k léčbě ischemické choroby končetin ve stadiu klidových bolestí a trofických změn (stadium III. a IV., tzv. „kritická ischemie“) po vyčerpání ostatních metod ke zhojení trofických defektů a odvrácení amputace. Podmínkou je vyjádření cévního chirurga nebo invazivního angiologa o nemožnosti provedení revaskularizace ohrožené končetiny v dokumentaci.
| 62.3 | C01EB10 | adenosin | parent. | 15.00 | MG | 648,81 | O/INT,KAR,GER |
|---|---|---|---|---|---|---|---|
| 62.4 | C01EB15 | trimetazidin | p.o. | 40.00 | MG | 5,67 | P |
Trimetazidin je indikován u nemocných s angínou pectoris, u kterých nevedla monoterapie nebo kombinace β-blokátorů s blokátory kalciového kanálu či s nitráty k uspokojivé kontrole výskytu stenokardií nebo u nemocných, u kterých nelze β-blokátory nebo vazodilatancia použít.
| 63 | antihypertenziva – antiadrenergní látky a látky působící na hladké svalstvo arteriol, vč. Kombinací s diuretiky, perorální podání | ||||||
|---|---|---|---|---|---|---|---|
| 63.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1.00 | GM | 5,67 | |
| 63.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 5,40 | |
| 63.3 | C02AC02 | guanfacin | p.o. | 3.00 | MG | 5,40 | |
| 63.4 | C02AC05 | moxonidin do 0,2 mg v 1 tabletě včetně | p.o. | 0.30 | MG | 5,99 | |
| 63.5 | C02AC05 | moxonidin nad 0,2 mg v 1 tabletě | p.o. | 0.30 | MG | 5,40 | |
| 63.6 | C02AC06 | rilmenidin | p.o. | 1.00 | MG | 5,40 | |
| 63.7 | C02CA | metazosin | p.o. | 20.00 | MG | 5,40 | |
| 63.8 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5.00 | MG | 12,30 | |
| 63.9 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5.00 | MG | 3,38 | |
| 88173 | DEPRAZOLIN | tbl 30x2mg | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 63.10 | C02CA06 | urapidil | p.o. | 50.00 | MG | 6,73 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 63.11 | C02DB01 | dihydralazin | p.o. | 75.00 | MG | 1,95 | |
| 63.12 | C02DB03 | endralazin | p.o. | 10.00 | MG | 9,22 | |
| 63.13 | C02DC01 | minoxidil | p.o. | 20.00 | MG | 19,68 | L/INT, KAR, GER |
| 63.14 | C02LA51 | reserpin a diuretika | p.o. | 1.00 | DF | 1,59 | |
| 63.15 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3.00 | DF | 4,83 | |
| 63.16 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2.00 | DF | 3,34 | |
| 63.17 | C02KX01 | bosentan | p.o. | 250.00 | MG | 2 816,10 | P |
Bosentan je předepisován k léčbě pacientů sarteriální plicní hypertenzí ve funkční třídě III. a IV. dle klasifikace NYHA. Bosentan předepisuje lékař specializovaného pracoviště - centra se zvláštní smlouvou se zdravotními pojišťovnami na léčbu tímto typem léčivého přípravku.
| 64 | antihypertenziva, ostatní cesty aplikace | ||||||
|---|---|---|---|---|---|---|---|
| 64.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 69,06 | H |
| 64.2 | C02CA06 | urapidil | parent. | 50.00 | MG | 198,79 | O |
| 90763 | EBRANTIL I.V. 25 | inj sol 5x5ml/25mg | AKZ | D | |||
| --- | --- | --- | --- | --- | |||
| 90765 | EBRANTIL I.V. 50 | inj sol 5x10ml/50mg | AKZ | D | |||
| 64.3 | C02DA01 | diazoxid | parent. | 300.00 | MG | 209,75 | H |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 64.4 | C02DB01 | dihydralazin | parent. | 25.00 | MG | 29,20 | H |
| 64.5 | C02DD01 | nitroprusid sodný | parent. | 50.00 | MG | 245,29 | H |
| 65 | diuretika s nižším diuretickým účinkem | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 65.1 | C03AA03 | hydrochlorothiazid | p.o. | 25.00 | MG | 0,97 | |
| 65.2 | C03B | cikletanin | p.o. | 50.00 | MG | 1,01 | |
| 65.3 | C03BA | metipamid | p.o. | 2.50 | MG | 1,01 | |
| 65.4 | C03BA04 | chlortalidon | p.o. | 25.00 | MG | 0,62 | |
| 65.5 | C03BA10 | xipamid | p.o. | 20.00 | MG | 1,01 | |
| 65.6 | C03BA11 | indapamid | p.o. | 2.50 | MG | 1,09 | |
| 46635 | INDAPAMID HF | tbl obd 30x2.5mg | HMF | YU | |||
| --- | --- | --- | --- | --- | |||
| 65.7 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1.50 | MG | 1,50 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 66 | diuretika s vysokým účinkem, perorální podání | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 66.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40.00 | MG | 0,79 | |
| 02079 | FUROSEMID-SLOVAKOFARMA | tbl 20x40mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 15332 | APO-FUROSEMIDE 80 MG | tbl 100x80mg | CMG | IRL | |||
| 15335 | APO-FUROSEMIDE 40 MG | tbl 100x40mg | CMG | IRL | |||
| 56347 | APO-FUROSEMIDE 40MG | tbl 100x40mg | APT | CND | |||
| 56804 | FURORESE 40 | tbl 50x40mg | SFS | D | |||
| 56805 | FURORESE 40 | tbl 100x40mg | SFS | D | |||
| 96738 | APO-FUROSEMIDE 80MG | tbl 100x80mg | APT | CND | |||
| 98219 | FURON 40 MG | por tbl nob 50x40mg | MCK | D | |||
| 66.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40.00 | MG | 0.62 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 17854 | FURORESE 125 | por tbl nob30x125mg | HPZ | PL | |||
| --- | --- | --- | --- | --- | |||
| 17855 | FURORESE 125 | por tbl nob50x125mg | HPZ | PL | |||
| 17856 | FURORESE 125 | por tblnob100x125mg | HPZ | PL | |||
| 56807 | FURORESE 125 | tbl 30x125mg | SFS | D | |||
| 56808 | FURORESE 125 | tbl 50x125mg | SFS | D | |||
| 56810 | FURORESE 250 | por tbl nob20x250mg | SFS | D | |||
| 56811 | FURORESE 250 | por tbl nob50x250mg | SFS | D | |||
| 56812 | FURORESE 250 | por tblnob100x250mg | SFS | D | |||
| 56814 | FURORESE 500 | tbl 50x500mg | SFS | D | |||
| 56815 | FURORESE 500 | tbl 100x500mg | SFS | D | |||
| 68632 | FURORESE 500 | tbl 20x500mg | SFS | D | |||
| 81498 | FUROSEMID AL 500 | por tbl nob50x500mg | APA | D | |||
| 81499 | FUROSEMID AL 500 | por tblnob100x500mg | APA | D | |||
| 98937 | FURORESE 250 | por tbl nob10x250mg | SFS | D | |||
| 66.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15.00 | MG | 0,79 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 66.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15.00 | MG | 0,62 | |
| 67 | diuretika s vysokým účinkem, ostatní cesty aplikace | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 67.1 | C03C | kyselina etakrynová | parent. | 50.00 | MG | 531,29 | O |
| 67.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40.00 | MG | 7,19 | O |
| 56819 | FURORESE ROZTOK | inf 5x25ml/250mg | PHH | D | |||
| --- | --- | --- | --- | --- | |||
| 56820 | FURORESE ROZTOK | inf 25x25ml/250mg | PHH | D | |||
| 67.3 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40.00 | MG | 15.16 | O |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 56818 | FURORESE 20 INJEKT | inj 25x2ml/20mg | PHH | D | |||
| --- | --- | --- | --- | --- | |||
| 67.4 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15.00 | MG | 15,67 | O |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 67.5 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15.00 | MG | 7,54 | O |
| 68 | diuretika šetřící draslík | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 68.1 | C03DA01 | spironolakton | p.o. | 75.00 | MG | 4,64 | |
| 68.2 | C03DA04 | eplerenon | p.o. | 50.00 | MG | 26,35 | P |
Eplerenon předepisuje kardiolog ve 2.volbě při doložené, klinicky závažné intoleranci spironolaktonu pouze jako doplněk standardní terapie u výrazně symptomatických nemocných s dysfunkcí levé komory (LVEF méně nebo rovno než 35%) a s klinickými známkami srdečního selhání po nedávno prodělaném infarktu myokardu.
| 68.3 | C03DB01 | amilorid | p.o. | 10.00 | MG | 1,53 | |
|---|---|---|---|---|---|---|---|
| 87662 | AMICLARAN | tbl 50x5mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 68.4 | C03DB02 | triamteren | p.o. | 100.00 | MG | 1,19 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 69 | kombinace diuretik | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 69.1 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.50 | DF | 0,49 | |
| 47476 | LORADUR | por tbl nob 50 | MCK | D | |||
| --- | --- | --- | --- | --- | |||
| 47478 | LORADUR MITE | por tbl nob 50 | MCK | D | |||
| 83717 | AMILORID/HCT AL | tbl 50 | APA | D | |||
| 83718 | AMILORID/HCT AL | tbl 100 | APA | D | |||
| 69.2 | C03EA06 | chlorthalidon a kalium šetřící látky | p.o. | 1.00 | DF | 1,08 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 69.3 | C03EA14 | spironolakton/butizid | p.o. | 1.00 | DF | 9,56 | |
| 70 | periferní vazodilatancia, perorální podání | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 70.1 | C04AC01 | kyselina nikotinová | p.o. | 0.20 | GM | 0,43 | |
| 70.2 | C04AD02 | xantinol nikotinát | p.o. | 0.90 | GM | 3,78 | |
| 70.3 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1.00 | GM | 3,40 | |
| 70.4 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1.00 | GM | 4,19 | |
| 70.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1.00 | GM | 4,75 | |
| 70.6 | C04AD04 | etophyllin nikotinát | p.o. | 0.30 | GM | 1,61 | |
| 70.7 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3.00 | MG | 2,08 | |
| 91032 | SECATOXIN FORTE | por gtt sol 1x25ml | IXP | CZ | |||
| --- | --- | --- | --- | --- | |||
| 70.8 | C04AE02 | nicergolin | p.o. | 30.00 | MG | 8,31 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 05742 | ERGOTOP 30 | por tbl flm 28x30mg | IVX | CZ | |||
| --- | --- | --- | --- | --- | |||
| 70.9 | C04AE54 | dihydroergokristin, kombinace | p.o. | 2.00 | ML | 1,90 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 70.10 | C04AX | jiná periferní vasodilatancia | p.o. | 3.00 | DF | 4,19 | |
| 70.11 | C04AX02 | fenoxybenzamin | p.o. | 30.00 | MG | 4,19 | |
| 70.12 | C04AX19 | sulkotidil | p.o. | 0.30 | GM | 4,19 | |
| 70.13 | C04AX20 | buflomedil | p.o. | 0.60 | GM | 4,19 | |
| 70.14 | C04AX21 | naftidrofuryl | p.o. | 0.20 | GM | 3,73 | |
| 71 | periferní vazodilatancia a vasoprotektiva, ostatní cesty aplikace | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 71.1 | C04AC | olamin nikotinát | parent. | 0.90 | GM | 19,59 | |
| 71.2 | C04AB01 | fentolamin | parent. | 10.00 | MG | 20,35 | O |
| 71.3 | C04AB02 | tolazolin | parent. | 75.00 | MG | 92.18 | O |
| 71.4 | C04AD | etophyllin/theophyllin | parent. | 0.30 | GM | 10,86 | |
| 71.5 | C04AD02 | xantinol nikotinát | parent. | 0.90 | GM | 4,15 | |
| 71.6 | C04AD03 | pentoxifylin | parent. | 0.30 | GM | 22.28 | |
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | |||
| --- | --- | --- | --- | --- | |||
| 69241 | PENTILIN INJEKCE 100MG/5ML | inj 5x5ml/100mg | KRK | SLO | |||
| 71.7 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3.00 | MG | 67,64 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 71.8 | C04AX | jiná periferní vasodilatancia | parent. | 2.00 | DF | 14,52 | |
| 71.9 | C04AX11 | bencyklan | parent. | 0.60 | GM | 50,35 | |
| 71.10 | C04AX21 | naftidrofuryl | parent. | 0.20 | GM | 52,73 | |
| 72 | vazoprotektiva a venofarmaka | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 72.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |
| 72.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1.00 | GM | 0,76 | |
| 72.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |
| 72.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1.00 | GM | 0,76 | |
| 72.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |
| 72.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1.00 | GM | 0,76 | |
| 72.7 | C05AX02 | bismutové přípravky, kombinace (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |
| 72.8 | C05AX02 | bismutové přípravky, kombinace (lékové formy mastí) | lok. | 1.00 | GM | 0,76 | |
| 72.9 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1.00 | DF | 0,96 | |
| 72.10 | C05AX03 | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1.00 | GM | 0,76 | |
| 72.11 | C05BA01 | organo-heparinoidy | lok. | 1.00 | GM | 0,70 | |
| 72.12 | C05BA03 | heparin k zevnímu použití | lok. | 1.00 | GM | 0,70 | |
| 86042 | HEPARIN AL MAST 30000 | ung 1x100gm | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | |||
| 72.13 | C05BA53 | heparin, kombinace k zevnímu použití | lok. | 1.00 | GM | 0,70 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 72.14 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1.00 | ML | 12.84 | O |
| 08510 | AETHOXYSKLEROL 0.5% | inj 5x2ml | KRS | D | |||
| --- | --- | --- | --- | --- | |||
| 08512 | AETHOXYSKLEROL 0.5% | inj 1x30ml | KRS | D | |||
| 72.15 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1.00 | ML | 13.34 | O |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml | KRS | D | |||
| --- | --- | --- | --- | --- | |||
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml | KRS | D | |||
| 72.16 | C05BB02 | polidokanol (nad 1% do 3 % včetně) | parent. | 1.00 | ML | 16.37 | O |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml | KRS | D | |||
| --- | --- | --- | --- | --- | |||
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml | KRS | D | |||
| 72.17 | C05BB02 | polidokanol (více než 3 %) | parent. | 1.00 | ML | 18,91 | O |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml | KRS | D | |||
| --- | --- | --- | --- | --- | |||
| 72.18 | C05BB04 | natrium tetradecyl sulfát (koncentrace do 1 % včetně) | parent. | 1.00 | ML | 13,34 | O |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 72.19 | C05BB04 | natrium tetradecyl sulfát (koncentrace nad 1%) | parent. | 1.00 | ML | 19,19 | O |
| 72.20 | C05BX01 | dobesilat vápenatý | p.o. | 0.75 | GM | 3,96 | |
| 72.21 | C05CA04 | troxerutin | p.o. | 3.00 | DF | 3,96 | |
| 72.22 | C05CA51 | rutosidy (kombinace, pevné lékové formy) | p.o. | 3.00 | DF | 1,27 | |
| 72.23 | C05CA51 | rutosidy (kombinace, tekuté lékové formy) | p.o. | 2.00 | ML | 2,96 | |
| 72.24 | C05CA53 | diosmin, kombinace | p.o. | 2.00 | DF | 3,96 | |
| 72.25 | C05CA54 | troxerutin, kombinace | p.o. | 2.00 | DF | 3,96 | |
| 72.26 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60.00 | MG | 3,96 | |
| 72.27 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5.00 | MG | 53,03 | H |
| 72.28 | C05CX01 | tribenosid | p.o. | 0.80 | GM | 3,96 | |
| 73 | neselektivní beta-blokátory, perorální podání | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 73.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10.00 | MG | 0,76 | |
| 73.2 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10.00 | MG | 0,28 | |
| 73.3 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10.00 | MG | 0,65 | |
| 73.4 | C07AA02 | oxprenolol | p.o. | 0.10 | GM | 2,68 | |
| 73.5 | C07AA03 | pindolol | p.o. | 15.00 | MG | 2,68 | |
| 73.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,68 | |
| 73.7 | C07AA07 | sotalol | p.o. | 0.16 | GM | 4,64 | L/KAR,INT, GER |
| 17847 | SOTAHEXAL 160 | por tbl nob20x160mg | HPZ | PL | |||
| --- | --- | --- | --- | --- | |||
| 17848 | SOTAHEXAL160 | por tbl nob50x160mg | HPZ | PL | |||
| 49012 | SOTAHEXAL 80 | por tbl nob 20x80mg | SFS | D | |||
| 49019 | SOTAHEXAL160 | por tblnob 20x160mg | SFS | D | |||
| 49020 | SOTAHEXAL160 | por tblnob 50x160mg | SFS | D | |||
| 83480 | SOTAHEXAL 80 | tbl 20x80mg | HEX | D | |||
| 83481 | SOTAHEXAL160 | tbl 20x160mg | HEX | D | |||
| 83670 | SOTAHEXAL160 | tbl 50x160mg | HEX | D | |||
| 85476 | SOTAHEXAL 80 | por tbl nob 20x80mg | HPZ | PL | |||
| 73.8 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2,68 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 73.9 | C07AA16 | tertatolol | p.o. | 5.00 | MG | 2,68 | |
| 73.10 | C07AA17 | bopindolol | p.o. | 1.00 | MG | 2,68 | |
| 73.11 | C07AA23 | penbutolol | p.o. | 40.00 | MG | 2,68 | |
| 73.12 | C07AA27 | kloranolol | p.o. | 20.00 | MG | 2,68 | |
| 74 | selektivní beta-blokátory a kombinace alfa a beta aktivity, perorální podání | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 74.1 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 2,46 | |
| 32673 | METOPROLOL AL 200 RETARD | por tbl pro50x200mg | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 47501 | METOPROLOL AL 200 RETARD | por tblpro100x200mg | APA | D | |||
| 74.2 | C07AB02 | metoprolol (do 50 mg včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,50 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 74.3 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) do 25 mg v jedné tabletě včetně | p.o. | 0.15 | GM | 12,61 | P |
| 74.4 | C07AB02 | metoprolol (léková forma tablety s řízeným uvolňováním) nad 25 mg v jedné tabletě | p.o. | 0.15 | GM | 7,82 | P |
Metoprolol v lékové formě tablet s řízeným uvolňováním je indikován v léčbě srdečního selhání; v dávce 25 mg je určen k zahájení léčby. Pouze v případech, kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 25 mg dlouhodobě. Cílová dávka metoprololu v lékové formě tablet s řízeným uvolňováním v indikaci srdečního selhání je 200 mg denně, k této udržovací dávce jsou indikovány tablety s obsahem 100 mg.
| 74.5 | C07AB02 | metoprolol (nad 50 mg v jedné tabletě) | p.o. | 0.15 | GM | 2,41 | |
|---|---|---|---|---|---|---|---|
| 47675 | METOPROLOLAL 100 | por tblnob 100x100mg | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 74.6 | C07AB03 | atenolol do 50 mg v jedné tabletě včetně p.o. | 75.00 | MG | 2,59 | ||
| --- | --- | --- | --- | --- | --- | --- | |
| 02951 | ATENOLOL AL 50 | por tbl nob100x50mg | APA | D | |||
| --- | --- | --- | --- | --- | |||
| 42457 | ATEHEXAL50 | por tbl flm 50x50mg | SFS | D | |||
| 42458 | ATEHEXAL50 | por tblflm100x50mg | SFS | D | |||
| 74.7 | C07AB03 | atenolol nad 50 mg v jedné tabletě | p.o. | 75.00 | MG | 1,89 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 42461 | ATEHEXAL100 | por tblflm 100x100mg | SFS | D | |||
| --- | --- | --- | --- | --- | |||
| 74.8 | C07AB04 | acebutolol | p.o. | 0.40 | GM | 3,37 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 46301 | ACEBIREX 200 MG | por tbl flm30x200mg | BTT | F | |||
| --- | --- | --- | --- | --- | |||
| 46303 | ACEBIREX 400 MG | por tbl flm30x400mg | BTT | F | |||
| 74.9 | C07AB05 | betaxolol | p.o. | 20.00 | MG | 3,37 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 95400 | BETAXA 20 | por tbl flm 30x20mg | ZEH | SK | |||
| --- | --- | --- | --- | --- | |||
| 95401 | BETAXA 20 | por tbl flm 60x20mg | ZEH | SK | |||
| 95402 | BETAXA 20 | por tbl flm 100x20mg | ZEH | SK | |||
| 74.10 | C07AB07 | bisoprolol | p.o. | 10.00 | MG | 3,37 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 32963 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D | |||
| --- | --- | --- | --- | --- | |||
| 32967 | BISOPROLOL-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | |||
| 32970 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D | |||
| 32974 | BISOPROLOL-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | |||
| 42870 | KORDOBIS 5 MG TBL. | por tbl flm 30x5mg | PVL | CZ | |||
| 42871 | KORDOBIS 10 MG TBL. | por tbl flm30x10mg | PVL | CZ | |||
| 74.11 | C07AB07 | bisoprolol hemifumarát do 2,5 mg v jedné tabletě včetně | p.o. | 10.00 | MG | 12,87 | P |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 74.12 | C07AB07 | bisoprolol hemifumarát nad 2,5 mg v jedné tabletě | p.o. | 10.00 | MG | 7,82 | P |
Bisoprolol je indikován v léčbě srdečního selhání; v dávce 2,5 mg je určen k zahájení léčby. Pouze v případech, kdy není pacientem tolerována dávka vyšší, je možné podávat v dávce 2,5 mg dlouhodobě. Cílová dávka bisoprololu v této indikaci je 10 mg denně a k udržovací léčbě je bisoprolol indikován v tabletách s obsahem 10 mg.
| 03824 | CONCOR COR 10 MG | tbl obd 28x10mg | MEC | D |
|---|---|---|---|---|
| 74.13 | C07AB08 | celiprolol | p.o. | 0.20 |
| --- | --- | --- | --- | --- |
| 74.14 | C07AB12 | nebivolol | p.o. | 5.00 |
Nebivolol je indikován v léčbě srdečního selhání. Nebivolol v dávce 5mg je určen k zahájení léčby. Cílová dávka nebivololu v této indikaci je 10 mg denně.
| 74.15 | C07AG01 | labetalol | p.o. | 0.60 | GM | 19,06 | L/KAR,INT,GER |
|---|---|---|---|---|---|---|---|
| 74.16 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.50 | MG | 12,87 | P |
| 74.17 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.50 | MG | 7,82 | P |
Karvedilol je indikován v léčbě srdečního selhání. Karvedilol v dávce 6,25 mg je určen k zahájení léčby. Pouze v případech, že není vyšší dávka tolerována, je možno podávat dávku 6,25 mg dlouhodobě. Cílová dávka karvedilolu v této indikaci je 25 – 50 mg denně, k udržovací léčbě je karvedilol indikován v tabletách s obsahem 12,5 a 25 mg.
| 75 | beta-blokátory, ostatní cesty aplikace | ||||||
|---|---|---|---|---|---|---|---|
| 75.1 | C07AA | metipranolol | parent. | 10.00 | MG | 62,82 | O |
| 85886 | TRIMEPRANOL | inj 10x1 ml/1 mg | HBS | SK | |||
| --- | --- | --- | --- | --- | |||
| 75.2 | C07AG01 | labetalol | parent. | 0.60 | GM | 1 004,27 | H |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 75.3 | C07AA | talinolol | parent. | 50.00 | MG | 91,52 | O |
| 75.4 | C07AA02 | oxprenolol | parent. | 0.10 | GM | 96,88 | O |
| 75.5 | C07AA03 | pindolol | parent. | 15.00 | MG | 96,88 | O |
| 75.6 | C07AA07 | sotalol | parent. | 0.16 | GM | 876.85 | O |
| 75.7 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1 366,44 | O |
| 75.8 | C07AB03 | atenolol | parent. | 75.00 | MG | 1 788.15 | O |
| 75.9 | C07AB04 | acebutolol | parent. | 0.40 | GM | 1 366,44 | O |
| 75.10 | C07AB09 | esmolol | parent. | 2.50 | GM | 3 737.59 | O |
| 76 | kombinace beta-blokátorů s jinými antihypertenzivy | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 76.1 | C07BB03 | atenolol a thiazidy | p.o. | 1.00 | DF | 4,16 | |
| 76715 | TENORETIC | por tbl flm 28 | AZC | GB | |||
| --- | --- | --- | --- | --- | |||
| 76.2 | C07BB07 | bisoprolol a thiazidy | p.o. | 1.00 | DF | 3,60 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 76.3 | C07CA17 | bopindolol a thiazidy | p.o. | 1.00 | DF | 4,31 | |
| 76.4 | C07FA | beta-blokátory, neselektivní, a jiná antihypertensiva | p.o. | 0.50 | DF | 0,71 | |
| 77 | blokátory vápníkového kanálu ze skupiny dihydropyridinů, perorální podání | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.1 | C08CA01 | amlodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 4,79 | |
| 02945 | AGEN5 | por tbl nob 30x5mg | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 03936 | AMLOPP-5 | por tbl nob 30x5mg | SDD | CZ | |||
| 03993 | NORMODIPINE 5 MG | por tbl nob 30x5mg | GED | H | |||
| 03998 | CARDILOPIN 5 MG | por tbl nob 30x5mg | EGI | H | |||
| 13464 | ORCAL 5 MG | por tbl nob90x5mg | LEK | SLO | |||
| 15378 | AGEN 5 | por tbl nob 90x5mg | ZEH | CZ | |||
| 19440 | ORCAL 5 MG TABLETY | por tbl nob30x5mg | LSW | PL | |||
| 19444 | ORCAL 5 MG TABLETY | por tbl nob90x5mg | LSW | PL | |||
| 32924 | ZOREM 5 MG | por tbl nob 30x5mg | PVL | CZ | |||
| 42833 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 30x5mg | MCK | D | |||
| 42837 | AMLODIPIN-RATIOPHARM 5 MG | por tbl nob 100x5mg | MCK | D | |||
| 42848 | HIPRES 5 | por tbl nob 30x5mg | KRK | SLO | |||
| 58415 | ORCAL 5MG | tbl 30x5mg | LEK | SLO | |||
| 58874 | AMLOZEK 5 | por tbl nob 30x5mg | ADD | PL | |||
| 95582 | ZOREM 5 MG | por tbl nob 100x5mg | PVL | CZ | |||
| 77.2 | C08CA01 | amlodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 3,83 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02954 | AGEN 10 | por tbl nob 30x10mg | ZEH | CZ | |||
| --- | --- | --- | --- | --- | |||
| 03944 | AMLOPP-10 | por tbl nob 30x10mg | SDD | CZ | |||
| 03999 | CARDILOPIN 10 MG | por tbl nob 30x10mg | EGI | H | |||
| 13466 | ORCAL 10 MG | por tbl nob90x10mg | LEK | SLO | |||
| 13851 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob 30x10mg | MCK | D | |||
| 13852 | AMLODIPIN-RATIOPHARM 10 MG | por tbl nob100x10mg | MCK | D | |||
| 15379 | AGEN 10 | por tbl nob 90x10mg | ZEH | CZ | |||
| 19442 | ORCAL 10 MG TABLETY | por tbl nob30x10mg | LSW | PL | |||
| 19446 | ORCAL 10 MG TABLETY | por tbl nob90x10mg | LSW | PL | |||
| 42849 | HIPRES 10 | por tbl nob 30x10mg | KRK | SLO | |||
| 58417 | ORCAL 10MG | tbl 30x10mg | LEK | SLO | |||
| 58876 | AMLOZEK 10 | por tbl nob 30x10mg | ADD | PL | |||
| 77.3 | C08CA02 | felodipin do 5 mg v 1 tbl včetně | p.o. | 5.00 | MG | 4,79 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02957 | PRESID 5 MG | por tbl ret 30x5mg | IXP | CZ | |||
| --- | --- | --- | --- | --- | |||
| 02961 | PRESID 2.5 MG | por tbl ret30x2.5mg | IXP | CZ | |||
| 20394 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro 30x5mg | MCK | D | |||
| 20397 | FELODIPIN-RATIOPHARM 5 MG | por tbl pro100x5mg | MCK | D | |||
| 21534 | FELOCOR 5 | por tbl pro 30x5mg | SFS | D | |||
| 21548 | FELOCOR 5 | por tbl pro 30x5mg | HED | DK | |||
| 42942 | FELODIPIN AL 5 RETARD | por tbl ret 30x5mg | APA | D | |||
| 48584 | FELOCOR 5 | por tbl pro 30x5mg | SFS | D | |||
| 48595 | FELOCOR 5 | por tbl pro 30x5mg | HED | DK | |||
| 77.4 | C08CA02 | felodipin nad 5 mg v 1 tbl | p.o. | 5.00 | MG | 3,83 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 02959 | PRESID 10 MG | por tbl ret 30x10mg | IXP | CZ | |||
| --- | --- | --- | --- | --- | |||
| 20317 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro 30x10mg | MCK | D | |||
| 20320 | FELODIPIN-RATIOPHARM 10 MG | por tbl pro100x10mg | MCK | D | |||
| 21504 | FELOCOR 10 | por tbl pro 30x10mg | SFS | D | |||
| 21519 | FELOCOR 10 | por tbl pro 30x10mg | HED | DK | |||
| 42946 | FELODIPIN AL 10 RETARD | por tbl ret 30x10mg | APA | D | |||
| 48608 | FELOCOR 10 | por tbl pro 30x10mg | SFS | D | |||
| 48619 | FELOCOR 10 | por tbl pro 30x10mg | HED | DK | |||
| 77.5 | C08CA03 | Isradipin | p.o. | 5.00 | MG | 4,54 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.6 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5.00 | MG | 4,79 | |
| 77.7 | C08CA05 | nifedipin | p.o. | 30.00 | MG | 1,42 | |
| 77.8 | C08CA05 | nifedipin (lékové formy s retardací 24 hodin) | p.o. | 1.00 | DF | 4,79 | |
| 03033 | CORDIPIN XL | tbl ret 30x40mg | KRK | SLO | |||
| --- | --- | --- | --- | --- | |||
| 53372 | NIFECARD XL 30MG | tbl ret 30x30mg | LEK | SLO | |||
| 77.9 | C08CA05 | nifedipin (retardované lékové formy s obsahem 20 mg) | p.o. | 30.00 | MG | 1,98 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 47490 | CORINFAR 20 RETARD | por tbl pro 30x20mg | AWD | D | |||
| --- | --- | --- | --- | --- | |||
| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | |||
| 77.10 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30.00 | MG | 1,34 | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 77.11 | C08CA06 | nimodipin | p.o. | 0.30 | GM | 131.86 | P |
Nimodipin je indikován u pacientů s ischemickými komplikacemi způsobenými arteriálním spasmem při subarachnoideálním krvácení. Léčba musí započít do 4 dnů po začátku krvácení a má trvat 21 dní.
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)